Kura Oncology (KURA) Short term Debt (2015 - 2025)

Kura Oncology (KURA) reported Short term Debt of $4.3 million for Q3 2025, up 152.89% year-over-year from $1.7 million in Q3 2024, and up 39.36% on a QoQ basis from $3.1 million in Q2 2025.

Kura Oncology (KURA) has 8 years of Short term Debt data on file, last reported at $4.3 million in Q3 2025.

  • Quarterly Short term Debt rose 152.89% year-over-year to $4.3 million in Q3 2025, while the trailing twelve-month figure through Sep 2025 was $4.3 million (up 152.89% YoY) and the FY2024 annual result came in at $2.6 million, changed N/A from the prior year.
  • Short term Debt grew to $4.3 million in Q3 2025 per KURA's latest filing, from $3.1 million in the prior quarter.
  • Across five years, Short term Debt topped out at $4.3 million in Q3 2025 and bottomed at $847000.0 in Q2 2024.
  • The 3-year median for Short term Debt is $2.6 million (2024), against an average of $2.5 million.
  • Peak annual rise in Short term Debt reached 267.41% in 2025, while the deepest fall reached 152.89% in 2025.
  • Tracing KURA's Short term Debt over 3 years: stood at $3.0 million in 2021, then declined by 13.1% to $2.6 million in 2024, then jumped by 66.36% to $4.3 million in 2025.
  • Per Business Quant, the three latest KURA Short term Debt figures stand at $4.3 million (Q3 2025), $3.1 million (Q2 2025), and $1.9 million (Q1 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn
7 Evaxion A 62.56 Bn 62.54 Bn -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn
10 Kura Oncology 801.92 Mn 801.92 Mn 18.00 Mn

Historic Data

Download Data 🔒
DateValue
Sep 30, 2025 4.34 Mn
Jun 30, 2025 3.11 Mn
Mar 31, 2025 1.92 Mn
Dec 31, 2024 2.61 Mn
Sep 30, 2024 1.72 Mn
Jun 30, 2024 847,000.00
Mar 31, 2021 3.00 Mn
Dec 31, 2020 3.00 Mn
Sep 30, 2020 2.50 Mn
Jun 30, 2020 1.75 Mn
Mar 31, 2020 1.00 Mn
Dec 31, 2019 250,000.00
Sep 30, 2018 2.83 Mn
Jun 30, 2018 2.81 Mn
Mar 31, 2018 2.29 Mn
Dec 31, 2017 1.53 Mn
Sep 30, 2017 1.02 Mn
Jun 30, 2017 500,000.00
Dec 31, 2015 232,000.00
Sep 30, 2015 232,000.00